Universal flu vaccine the holy grail for researchers

05/19/2009 | NYTimes.com

The threat of a swine flu pandemic has prompted scientists and vaccine manufacturers to ramp up efforts to develop a universal influenza vaccine that can provide protection for years, if not a lifetime, against pandemic and seasonal strains. VaxInnate, Merck & Co. and Sanofi-Aventis unit Acambis are exploring the M2 protein that is found inside the flu virus, and other researchers are focusing on isolating the hemagglutinin protein outside the virus as a starting point in creating a universal vaccine.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC